Gebo KA - Search Results

1

Risk Factors for Hospitalization and Effect of Immunosuppression on Clinical Outcomes Among an Urban Cohort of Patients With Mpox.

Garneau WM, Jones JL, Dashler GM, Mostafa HH, Judson SD, Kwon N, Hamill MM, Gilliams EA, Rudolph DS, Keruly JC, Fall A, Klein EY, Hansoti B, Gebo KA. Garneau WM, et al. Among authors: gebo ka. Open Forum Infect Dis. 2023 Dec 5;10(12):ofad533. doi: 10.1093/ofid/ofad533. eCollection 2023 Dec. Open Forum Infect Dis. 2023. PMID: 38058459 Free PMC article.

2

Risk factors for pneumococcal disease in human immunodeficiency virus-infected patients.

Gebo KA, Moore RD, Keruly JC, Chaisson RE. Gebo KA, et al. J Infect Dis. 1996 Apr;173(4):857-62. doi: 10.1093/infdis/173.4.857. J Infect Dis. 1996. PMID: 8603963

3

Association of social stress, illicit drug use, and health beliefs with nonadherence to antiretroviral therapy.

Gebo KA, Keruly J, Moore RD. Gebo KA, et al. J Gen Intern Med. 2003 Feb;18(2):104-11. doi: 10.1046/j.1525-1497.2003.10801.x. J Gen Intern Med. 2003. PMID: 12542584 Free PMC article.

4

Absolute CD4 vs. CD4 percentage for predicting the risk of opportunistic illness in HIV infection.

Gebo KA, Gallant JE, Keruly JC, Moore RD. Gebo KA, et al. J Acquir Immune Defic Syndr. 2004 Aug 15;36(5):1028-33. doi: 10.1097/00126334-200408150-00005. J Acquir Immune Defic Syndr. 2004. PMID: 15247555

5

An improvement in virologic response to highly active antiretroviral therapy in clinical practice from 1996 through 2002.

Moore RD, Keruly JC, Gebo KA, Lucas GM. Moore RD, et al. Among authors: gebo ka. J Acquir Immune Defic Syndr. 2005 Jun 1;39(2):195-8. J Acquir Immune Defic Syndr. 2005. PMID: 15905736

6

Illicit drug use and HIV-1 disease progression: a longitudinal study in the era of highly active antiretroviral therapy.

Lucas GM, Griswold M, Gebo KA, Keruly J, Chaisson RE, Moore RD. Lucas GM, et al. Among authors: gebo ka. Am J Epidemiol. 2006 Mar 1;163(5):412-20. doi: 10.1093/aje/kwj059. Epub 2006 Jan 4. Am J Epidemiol. 2006. PMID: 16394200

7

Invasive pneumococcal disease in a cohort of HIV-infected adults: incidence and risk factors, 1990-2003.

Barry PM, Zetola N, Keruly JC, Moore RD, Gebo KA, Lucas GM. Barry PM, et al. Among authors: gebo ka. AIDS. 2006 Feb 14;20(3):437-44. doi: 10.1097/01.aids.0000206507.54901.84. AIDS. 2006. PMID: 16439878

8

Alcohol use among HIV-infected persons in care: results of a multi-site survey.

Chander G, Josephs J, Fleishman JA, Korthuis PT, Gaist P, Hellinger J, Gebo K; HIV Research Network. Chander G, et al. HIV Med. 2008 Apr;9(4):196-202. doi: 10.1111/j.1468-1293.2008.00545.x. HIV Med. 2008. PMID: 18366443 Free PMC article.

9

Rate of comorbidities not related to HIV infection or AIDS among HIV-infected patients, by CD4 cell count and HAART use status.

Moore RD, Gebo KA, Lucas GM, Keruly JC. Moore RD, et al. Among authors: gebo ka. Clin Infect Dis. 2008 Oct 15;47(8):1102-4. doi: 10.1086/592115. Clin Infect Dis. 2008. PMID: 18781885 Free PMC article.

10

Effect of age and HAART regimen on clinical response in an urban cohort of HIV-infected individuals.

Greenbaum AH, Wilson LE, Keruly JC, Moore RD, Gebo KA. Greenbaum AH, et al. Among authors: gebo ka. AIDS. 2008 Nov 12;22(17):2331-9. doi: 10.1097/QAD.0b013e32831883f9. AIDS. 2008. PMID: 18981772 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

243 results

Search Page

Filters